Search clinical trials for: PLX-R18

Total 2526 results

Pluristem Ltd.

Completed

Safety Evaluation of Intramuscular Injections of PLX-R18 in Subjects With Incomplete Hematopoietic Recovery Following Hematopoietic Cell Transplantation

Incomplete HCT (Hematopoietic Cell Transplantation)

United States, Israel
Pluristem Ltd.

Unknown

Open-label Phase I Study for PEP or Treatment of HS-ARS PLX-R18 for the Post-Exposure Prevention (PEP) or Treatment of Hematopoietic Syndrome of Acute Radiation Syndrome (HS-ARS) (HS-ARS)

Ionizing Radiation Exposure
Poznan University of Physical Education

Recruiting

Effects of β-alanine and Sodium Bicarbonate Supplementation on Physical Capacity and Biochemical Markers Concentrations

Supplementation | Sports | Female Athletes

Poland
Pluristem Ltd.

Completed

Safety and Efficacy of IM Injections of PLX-PAD for the Regeneration of Injured Gluteal Musculature After Total Hip Arthroplasty

Total Hip Arthroplasty | Muscle Injury

Germany
Hannah Choe, MD
National Cancer Institute (NCI); Plexxikon

Terminated

Novel BET Inhibitor PLX51107 for Steroid-Refractory Acute GVHD

Acute Graft Versus Host Disease | Steroid Refractory Graft Versus Host Disease

United States
WideTrial, Inc.

Available

Expanded Access for Treatment Use of PLX-PAD in Critical Limb Ischemia (CLI)

Critical Limb Ischemia (CLI)
Plexium, Inc.

Recruiting

First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors

Gastric Adenocarcinoma | Advanced Solid Tumor | Metastatic Solid Tumor | Esophageal Adenocarcinoma | Esophageal Squamous Cell Carcinoma | Gastric Squamous Cell Carcinoma | Non-Small Cell Lung Carcinoma | Gastroesophageal Junction (GEJ) Adenocarcinoma | Gastroesophageal Junction Squamous Cell Carcinoma | SMARCA4 Mutation

United States
Société des Produits Nestlé (SPN)

Completed

Effects of Specific Lipid Fractions-enriched Infant Formulae

Infant Growth

France, Italy
Pluristem Ltd.

Terminated

Open-label Multicenter Study to Evaluate the Efficacy of PLX-PAD for the Treatment of COVID-19

COVID | ARDS

Israel, Germany
Pluristem Ltd.

Completed

Safety of Intramuscular Injections (IM) of Allogeneic PLX-PAD Cells for the Treatment of Critical Limb Ischemia (CLI)

Peripheral Vascular Disease | Peripheral Artery Disease | Critical Limb Ischemia

United States
Pluristem Ltd.

Completed

Efficacy, Tolerability and Safety of Intramuscular Injections of PLX PAD for the Treatment of Subjects With Critical Limb Ischemia (CLI) With Minor Tissue Loss Who Are Unsuitable for Revascularization

Critical Limb Ischemia (CLI)

Germany, United Kingdom, Hungary, United States, Bulgaria, Czechia, Israel, North Macedonia, Poland
Pluristem Ltd.

Completed

Safety and Efficacy of Allogeneic Cells for the Treatment of Intermittent Claudication(IC)

Intermittent Claudication | Peripheral Artery Disease

United States, Germany, Korea, Republic of, Israel
Pluristem Ltd.

Completed

Safety of Intramuscular Injection of Allogeneic PLX-PAD Cells for the Treatment of Critical Limb Ischemia

Peripheral Vascular Disease | Peripheral Artery Disease | Critical Limb Ischemia

Germany
Siemens Molecular Imaging

Terminated

Exploratory, Phase I,Open Label,Non-randomized Study of [F18]CP-18 PET in Normal and Breast Cancer Subjects

Breast Cancer

United States
Pluristem Ltd.

No longer available

Expanded Access Treatment of Subjects With Critical Limb Ischemia (CLI) With Minor Tissue Loss Who Are Unsuitable for Revascularization

Critical Limb Ischemia (CLI)

United States
United Therapeutics

Terminated

Safety Study of PLX-PAD Cells to Treat Pulmonary Arterial Hypertension (PAH)

Pulmonary Arterial Hypertension

Australia
Movetis

Completed

Efficacy Study of Prucalopride to Treat Chronic Intestinal Pseudo-Obstruction (CIP)

Chronic Intestinal Pseudo-Obstruction

United Kingdom
Pluristem Ltd.

Terminated

Double-Blind, Multicenter, Study to Evaluate the Efficacy of PLX PAD for the Treatment of COVID-19

COVID | ARDS

United States
Pluristem Ltd.

Completed

Treatment of Muscle Injury Following Arthroplasty for Hip Fracture (HF)

Hip Fracture

United Kingdom, Bulgaria, Germany, United States, Israel
Pacylex Pharmaceuticals
Ozmosis Research Inc.

Completed

Study of PCLX-001 in R/R Advanced Solid Malignancies and B-cell Lymphoma

Advanced Solid Tumor | B-cell Non Hodgkin Lymphoma

Canada
University of Alicante

Completed

Study of the Effects of Plx on Bioparametric Measurements.

Quality of Life | Stress, Psychological | Sleep Initiation and Maintenance Disorders | Body Composition | Depression, Anxiety | Antidepressive Agents

Spain
RemeGen Co., Ltd.

Terminated

RC18 in Patients With Relapsing Remitting Multiple Sclerosis：a Phase II Trial

Multiple Sclerosis, Relapsing-Remitting

China
Avid Radiopharmaceuticals

Terminated

A Phase 0, Open Label, Multi-center Exploratory and Safety Study of [F-18]T807

Alzheimers Disease | AD

United States
Avid Radiopharmaceuticals

Terminated

A Phase 0, Open Label, Multi-Center, Exploratory and Safety Study of [F-18]T808 (T808)

Alzheimers Disease

United States
University of Split, School of Medicine
University Hospital of Split

Enrolling by invitation

Effectiveness of Original vs. AI-Generated Plain Language Summaries of Systematic Reviews

Non-Metastatic Breast Cancer

Croatia
Ralexar Therapeutics, Inc.

Completed

A Study in Subjects With Moderate Atopic Dermatitis

Atopic Dermatitis | Eczema, Atopic

United States
Centre hospitalier de l'Université de Montréal...
Université de Montréal

Completed

Implementation and Evaluation of a Perceptual Learning Module on the Identification of the Brachial Plexus (MAP-IS)

Medical Education

Canada
RemeGen Co., Ltd.

Completed

A Study of TACI-antibody Fusion Protein Injection (RC18) in Subjects With Primary Sjögren's Syndrome

Primary Sjögren's Syndrome

China
Changhai Hospital

Recruiting

Personalized Precision Diagnosis and Treatment of Pancreatic Cancer (PPDTPC)

Pancreatic Cancer

China
Ablynx, a Sanofi company

Completed

Phase III Trial With Caplacizumab in Patients With Acquired Thrombotic Thrombocytopenic Purpura (HERCULES)

Acquired Thrombotic Thrombocytopenic Purpura

United States, Australia, Austria, Belgium, Canada, Czechia, France, Germany, Hungary, Israel, Italy, Netherlands, Spain, Switzerland, Turkey, United Kingdom
Lawson Health Research Institute

Completed

Effect of EPD on the Lumbar Acoustic Window at Term Pregnancy

Effects of; Anesthesia, Spinal and Epidural, in Pregnancy
Oligomerix, Inc

Active, not recruiting

Phase 1 Study of OLX-07010 in Healthy Adult and Elderly Participants

Alzheimer Disease

United States
University Hospital, Rouen

Recruiting

Efficacy and Safety of Immunosuppression, Caplacizumab and Plasma Infusion Without Therapeutic Plasma Exchange in Immune-mediated Thrombotic Thrombocytopenic Purpura (PEX-FREE)

Thrombotic Microangiopathies

France, Martinique, Reunion
RemeGen Co., Ltd.

Completed

A Study of TACI（Transmembrane Activator and Calcium-modulator and Cyclophilin Ligand (CAML) Interactor）-Antibody Fusion Protein Injection (RC18) in Subjects With Systemic Myasthenia Gravis

Systemic Myasthenia Gravis

China
Avid Radiopharmaceuticals

Completed

18F-AV-1451 High Resolution Autopsy Study

Alzheimer's Disease

United States
Cook Group Incorporated

Completed

Formula PTX Renal Stent Clinical Study

Renal Artery Stenosis

United Kingdom, Germany, Czechia, France
Duke University
National Institute of General Medical Sciences (NIGMS)

Completed

Delivery of Pharmacogenetic Testing in a Community Pharmacy Setting

Pharmacogenetics

United States
Ralexar Therapeutics, Inc.

Unknown

Study in Subjects With Moderate Atopic Dermatitis

Atopic Dermatitis Eczema

United States, Canada
Philips Respironics

Completed

Alice PDx User/Validation Extended Trial

Sleep Apnea | Sleep-Disordered Breathing

United States
Abramson Cancer Center at Penn Medicine

Recruiting

Multitracer [18F]Fluciclovine and 18F-FDG PET, and Advanced MRI for Metabolic Profiling of Glioblastoma (GBM)

Glioblastoma | Recurrent Glioblastoma | Glioblastoma Multiforme of Brain

United States
Johns Hopkins Bloomberg School of Public Health
National Institute on Drug Abuse (NIDA)

Completed

An Evaluation of an Integrated Approach to Prevention and Early Intervention in the Elementary School Years (P2P+IY)

Aggression

United States
Mesoblast, Ltd.

Withdrawn

Safety and Efficacy Study of NeoFuse in Subjects Requiring Posterolateral Lumbar Fusion

Degenerative Disc Disease | Spinal Stenosis | Degenerative Spondylolisthesis

United States
Meyer Children's Hospital IRCCS

Recruiting

TED_ORG: Study on Short Bowel Syndrome

Short Bowel Syndrome (SBS)

Italy
University of Michigan

Completed

Pharmacogenomic Testing in Primary Care

Antidepressants Causing Adverse Effects in Therapeutic Use

United States
Cook Group Incorporated

Completed

Zilver PTX Drug-Eluting Peripheral Stent Study

Peripheral Arterial Disease

Germany, Switzerland
Prescient Therapeutics, Ltd.

Recruiting

A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL

CTCL

Australia, United States, France, Italy
Proviva Therapeutics, Inc.

Recruiting

A First-in-human (FIH), Phase I Study of PTX-912 in Patients with Locally Advanced/Metastatic Solid Tumors

Solid Tumor | Metastatic Cancer | Advanced Cancer

United States
Retension Pharmaceuticals. Inc.

Completed

Safety and Effect of Oral Doses of 5mg or 10mg of SLx-2101 for 14 Days in Patients With Hypertension

Hypertension

Germany
Retension Pharmaceuticals. Inc.

Completed

Safety and Effects of SLx-2101 Taken for up to 14 Days on Blood Pressure in Patients With Hypertension

Hypertension

United Kingdom
Prescient Therapeutics, Ltd.

Completed

Phase 1 Study of PTX-100 in Patients With Advanced Malignancies With PTCL Expansion Cohort

Advanced Cancer | PTCL

Australia

Search clinical trials for: PLX-R18

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cambodia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations